Asuragen Launches SMN1/2 Plus Kit

Last updated: 19th March, 2020

Abacus dx is pleased to announce the launch of the latest assay from the Asuragen spinal muscular atrophy (SMA) portfolio – AmplideX® PCR/CE SMN1/2 Plus Kit*.

SMA is an autosomal recessive disorder caused by loss of functional SMN1 found on chromosome 5. Affected individuals most commonly inherit two faulty SMN1 genes (copy number = 0), one from each parent. SMN2 can compensate for defective SMN1 therefore it is important to quantify both SMN1 and SMN2 copy number.

The latest assay from Asuragen quantifies SMN1 and SMN2 exon 7 copy number and also detects SMN1 gene duplication (“silent carrier”) and SMN2 disease modifier variants – all in a single reaction.

SMN1 and SMN2 copy number, silent carrier and disease modifier genotyping – in less than 4 hours

Reduced Complexity

  • Similar workflow to AmplideX® PCR/CE FMR1 Kit for easier implementation and training
  • Multiplexed, scalable design allows analysis of single-nucleotide variants, small indels and copy number changes from a single PCR reaction
  • Assay-specific software automates variant calls and simplifies data analysis

Optimised Workflow

  • DNA-to-data in less than 4 hours
  • Fully-kitted solution

Quality Performance

  • Ability to differentiate between 0, 1, 2, 3, and ≥4 copies for both SMN1 and SMN2
  • Automated variant and copy number genotyping

* Research Use Only. IVD-use kit coming soon

View more information about this kit

Download Brochure >

Contact us for a quote

Contact Us Now >
Go BackGo Back
Top